FOR IMMEDIATE RELEASE

ACS News Service Weekly PressPac: Wed May 16 16:42:03 EDT 2012

New, inexpensive paper-based diabetes test ideal for developing countries

With epidemics of Type 2 diabetes looming in rural India, China and other areas of the world where poverty limits the availability of health care, scientists are reporting development of an inexpensive and easy-to-use urine test ideally suited for such areas. The report describing the paper-based device, which also could be adapted for the diagnosis and monitoring of other conditions and the environment, appears in ACS’ journal Analytical Chemistry.

Jan Lankelma and colleagues point out that monitoring glucose levels is important. Although diabetes test strips seem inexpensive, the cost can be prohibitive in areas where people must choose between that and the essentials of life, such as food and shelter. In addition, current handheld diabetes monitoring devices measure glucose levels in blood, which requires a pin-prick to a finger — something that could deter patients from taking the measurements. To address these challenges, the researchers built a new type of glucose monitor — one that detects glucose levels in urine (which is easy to obtain) and is made from inexpensive materials, such as paper.

The device consists of three electrodes, a buffer solution, a piece of paper (or nitrocellulose) and a plastic dish. The sample is injected onto the paper with a slightly modified medical syringe, and the solution moves along the paper by gravity and capillary action. An enzyme called glucose oxidase is already on the paper, and it reacts with glucose in the sample to produce hydrogen peroxide, which is detected by the electrodes. The system can be built quickly, is inexpensive and produces results similar to those from a more expensive, commercially available clinical instrument. The authors state that the device could be used not only in a clinical lab, but it could also be further developed for applications as diverse as analyzing food quality and environmental monitoring.

The authors acknowledge funding from the Bill and Melinda Gates Foundation.

Contact

Science Inquiries: Michael Woods, Editor, 202-872-6293
General Inquiries
: Michael Bernstein, 202-872-6042

empty
Credit: Centers for Disease Control and Prevention
High-resolution image